Company joins Industry and Scientific Leaders int the Personalized Medicine Coalition
Panaceutics, Inc., a technology company serving the delivery of personalized medicine and clinical nutrition products direct to patients, today announced that it has joined the Personalized Medicine Coalition and has been invited to participate in the 13th Annual Personalized Medicine Conference on November 14th through 16th, hosted by Harvard Medical School in Boston, MA.
This year’s conference entitled “From Concept to the Clinic” perfectly captures the state of the personalized medicine industry which is now looking for ways to bring the large potential medical benefits arising from genomics, metabolomics, and advanced diagnostics to provide precision cures, manage chronic disease, and promote health and wellbeing.
Mark Montgomery, CEO of Panaceutics states “Panaceutics was founded on the belief that advanced genomic and data driven healthcare would revolutionize our understanding of disease and bring about more effective cures and management strategies for common diseases. While Panaceutics does not make a specific therapy, it is providing the tools, the picks and shovels to build this new highway of discovery, that doctors and clinicians will need to translate this new science into precision medications for large populations of patients.”
The company will present its products and technology to the world experts who attend this conference in Boston. The Company’s technical and management team will be present and available for in depth discussions with potential partners, researchers, and investors. ***